Skip to main content
KALA logo

KALA · KALA BIO, Inc. · Executive Compensation

Track KALA — free
$2.71 -0.31 (-10.28%) At close · Nov 20 Q2 2022 earnings call transcript
Market Cap
$1.74M
Shares
644,660
Volume · Nov 20 19.23K Avg daily vol (5 sessions) 17.3K

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025
Executive Total
Todd Bazemore $3,476,972
Kim Brazzell $1,358,174
Mary Reumuth $1,322,608
Mark Iwicki $906,642
Fiscal 2024
Executive Total
Mark Iwicki $1,491,187
Todd Bazemore $949,550
Kim Brazzell $920,687
Mary Reumuth $778,269
Fiscal 2023
Executive Total
Mark Iwicki $8,342,714
Todd Bazemore $2,943,656
Kim Brazzell $2,923,073
Fiscal 2022
Executive Total
Mark Iwicki $1,868,299
Todd Bazemore $1,025,817
Kim Brazzell $993,689
Fiscal 2021
Executive Total
Mark Iwicki $2,772,056
Todd Bazemore $1,343,356
Kim Brazzell $1,316,969

Executive changes

Person Change Filed
David Lazar
“Mr. Lazar’s resignation from the Board was not related to any disagreement with the Company on any matter relating to its operations, policies or practices.”
Resigned 2026-02-20
Avi Minkowitz Appointed 2026-02-05
Avi Minkowitz Appointed 2026-02-05
David Lazar Resigned 2026-02-05
David Lazar Resigned 2026-02-05
David Lazar Appointed 2026-02-02
Howard B. Rosen
“Each of Messrs. Farid, Koven, Iwicki, Bazemore, Meyers and Rosen’s resignations was due to the approval of the Issuance Proposal and the Share Increase Proposal at the Annual Meeting and did not arise or result from any disagreement with the Company on any matters relating to the Company’s operations, policies or practices.”
Resigned 2026-02-02
C. Daniel Meyers
“Each of Messrs. Farid, Koven, Iwicki, Bazemore, Meyers and Rosen's resignations was due to the approval of the Issuance Proposal and the Share Increase Proposal at the Annual Meeting and did not arise or result from any disagreement with the Company on any matters relating to the Company's operations, policies or practices.”
Resigned 2026-02-02
Mark Iwicki
“Each of Messrs. Farid, Koven, Iwicki, Bazemore, Meyers and Rosen's resignations was due to the approval of the Issuance Proposal and the Share Increase Proposal at the Annual Meeting and did not arise or result from any disagreement with the Company on any matters relating to the Company's operations, policies or practices.”
Resigned 2026-02-02
Todd Bazemore
“Each of Messrs. Farid, Koven, Iwicki, Bazemore, Meyers and Rosen's resignations was due to the approval of the Issuance Proposal and the Share Increase Proposal at the Annual Meeting and did not arise or result from any disagreement with the Company on any matters relating to the Company's operations, policies or practices.”
Resigned 2026-02-02
Andrew I. Koven
“Each of Messrs. Farid, Koven, Iwicki, Bazemore, Meyers and Rosen's resignations was due to the approval of the Issuance Proposal and the Share Increase Proposal at the Annual Meeting and did not arise or result from any disagreement with the Company on any matters relating to the Company's operations, policies or practices.”
Resigned 2026-02-02
Marjan Farid
“Each of Messrs. Farid, Koven, Iwicki, Bazemore, Meyers and Rosen's resignations was due to the approval of the Issuance Proposal and the Share Increase Proposal at the Annual Meeting and did not arise or result from any disagreement with the Company on any matters relating to the Company's operations, policies or practices.”
Resigned 2026-02-02
Howard B. Rosen
“The resignations were not due to any disagreement with the Company on any matter relating to its operations, policies or practices.”
Resigned 2025-12-29
Todd Bazmore
“The resignations were not due to any disagreement with the Company on any matter relating to its operations, policies or practices.”
Resigned 2025-12-29
C. Daniel Myers
“The resignations were not due to any disagreement with the Company on any matter relating to its operations, policies or practices.”
Resigned 2025-12-29
Mark Iwicki
“The resignations were not due to any disagreement with the Company on any matter relating to its operations, policies or practices.”
Resigned 2025-12-29
Andrew I. Koven
“The resignations were not due to any disagreement with the Company on any matter relating to its operations, policies or practices.”
Resigned 2025-12-29
Marjan Farid, M.D.
“The resignations were not due to any disagreement with the Company on any matter relating to its operations, policies or practices.”
Resigned 2025-12-29
David Lazar Appointed 2025-11-25
David Lazar Appointed 2025-11-25
Todd Bazemore Terminated 2025-10-20
Todd Bazemore Appointed 2025-09-02
Todd Bazemore Appointed 2025-09-02
Todd Bazemore Appointed 2025-02-12
Mark Iwicki Resigned 2025-02-12

Leadership

Key facts CIK 1479419 CUSIP 483119301 13F (30d) 23 filings 19 filers Visit website Investor relations